Format

Send to

Choose Destination
Front Physiol. 2018 Dec 10;9:1777. doi: 10.3389/fphys.2018.01777. eCollection 2018.

Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction.

Author information

1
Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, Houston, TX, United States.
2
Institut National de la Santé et de la Recherche Médicale UMR_S 999, Le Plessis-Robinson, France.
3
Université Paris-Sud and Université Paris-Saclay, Le Kremlin-Bicêtre, France.
4
Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
5
Otto Loewi Research Center, Division of Physiology, Medical University of Graz, Graz, Austria.
6
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
7
Department of Medicine, Queen's University, Kingston, ON, Canada.
8
Department of Surgery, Queen's University, Kingston, ON, Canada.

KEYWORDS:

endothelial cell (EC); pulmonary hypertension (PH); pulmonary hypertension (PH) due to lung diseases and/or hypoxemia; right ventricle (RV) function; vascular smooth muscle

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center